ICON News

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Clinical research group Icon has reported a net profit of $24m for the third quarter of this year, up 12% from the same period a year earlier.

ICON has received industry accreditations for three of its laboratories. The company's bioanalytical lab in Manchester, UK received GCP and GLP accreditation from the MHRA , covering bioanalysis of small molecules by mass spectrometry and large molecules by immunoassay techniques.

If you're looking for an indicator of the drug industry's future research and development efforts, keep an eye on contract research organizations , which conduct research for drug giants like Pfizer and Merck , as well as smaller companies.

ICON advises that all resolutions recommended by the Board at the Annual General Meeting of the Company held on 20 July 2009 were duly passed.

Good afternoon, ladies and gentleman, and welcome to the ICON plc Second Quarter 2009 Earnings Conference Call.

ICON plc, , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that is has acquired Veeda Laboratories Ltd., a wholly-owned subsidiary of Veeda Clinical Research Group.

ICON plc , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has moved its Singapore central laboratory to a new, larger facility located at Loyang Way, Eastern Singapore.

Strategic Partnership Leverages ICON's Extensive European Capabilities DUBLIN, June 9 /CNW/ - ICON plc, , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has signed a strategic partnership with Eli Lilly and Company to manage the company's clinical ...

Dublin, Ireland, May 11th, 2009 - ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has again been named as a favourite Contract Research Organisation to work with, according to a recent independent survey of pharmaceutical and biotechnology ...

First Quarter Fiscal 2009 * First quarter net revenues increased 9% over the comparative quarter, to $219.8 million.

ICON plc , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has acquired a 33,000-square-foot Phase I facility with a capacity of up to 100 beds in Omaha, Nebraska, having acquired the assets of the former Qualia Clinical Services, Inc.

OTC Select tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts by visiting OTC Select at the following: http://www.otcselect.com. Today's alerts include: Corinthian Colleges, Inc.